SBIJI Innovation
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002...
Search
SBIJI Innovation
- Jul 6, 2021
- 1 min
Advaxis and Biosight Announce Entry into Definitive Merger Agreement
MONMOUTH JUNCTION, N.J. and AIRPORT CITY, Israel, July 06, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (“Advaxis”) (NASDAQ: ADXS) and Biosight...
23 views0 comments
SBIJI Innovation
- Jun 13, 2021
- 1 min
LogicBio Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial
LogicBio Therapeutics Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial for the Treatment of Pediatric...
15 views0 comments
SBIJI Innovation
- Apr 28, 2021
- 1 min
Chemomab Announces Enrollment of First Patient in Phase 2a Study of CM-101 in NASH
The study aims to further validate the anti-fibrotic and anti-inflammatory activity of CM-101 while providing safety and PK data to...
14 views0 comments
SBIJI Innovation
- Apr 28, 2021
- 1 min
LogicBio Therapeutics Announces Research Collaboration with Daiichi Sankyo
- Under the terms of the research collaboration and exclusive option agreement, the companies will initiate a gene editing research...
11 views0 comments